Skelid and Breastfeeding: An Overview
At this time, it is unknown if
Skelid® (
tiludronate disodium) passes through breast milk in humans. The manufacturer of Skelid recommends that it be used cautiously in breastfeeding women. This means that you and your healthcare provider should weigh the potential risks and benefits and that you and your infant should be monitored closely if you decide to take Skelid. If you are breastfeeding or are thinking about breastfeeding, you should talk with your healthcare provider before taking Skelid.
Skelid and Breastfeeding: What Does the Research Say?
No studies have been done to see if Skelid passes through breast milk. If your healthcare provider recommends taking Skelid while breastfeeding, be sure to watch for any side effects in your child. Skelid is incorporated into bone and is slowly released over time. It is not known how Skelid might affect growing bones (if, in fact, it does pass through breast milk). Therefore, many healthcare providers do not recommend that women breastfeed while taking Skelid.
You may wonder why no studies have been done to see if Skelid is safe to use during breastfeeding. Such studies are usually considered to be unethical, for several reasons. Importantly, the breastfeeding child cannot consent to the study. Also, the child would be exposed to unknown risks, without the possibility of directly experiencing any benefit from the medication. Most of the information known about using medications during breastfeeding is gathered from experience in women who choose to take the medications (outside of clinical studies).